Drugmaker's $15 Billion Rally in 11 Days Attracts New Bear Call

(Bloomberg) -- After a 57 percent stock rally in 11 trading days this year, one analyst has decided that now is the time to give South Korea’s Celltrion Inc. a sell rating.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.